Mark Kendall, the guitarist for the legendary rock band Great White, first announced that he has been battling stage 4 kidney ...

Longtime Texas high school football coach Mike Robinson has died, DeSoto coach Claude Mathis confirmed to The Dallas Morning ...

Tiziana Life Sciences (TLSA) announces the submission of its seventh annual Development Safety Update Report to the U.S. Food ...

My words, thoughts, and ideas are now submerged deep in a vat of midnight dark molasses and some days I can no longer ...

US FDA grants fast track designation to Complement Therapeutics’ gene therapy candidate CTx001 to treat geographic atrophy: Munich Saturday, January 10, 2026, 17:00 Hrs [IST] Co ...

January 07, 2026-- NeuraLight, the leader in developing precision biomarkers for neurology, today announced the completion of PALOMA, a pioneering study comparing eye-movement measures with standard ...

Tiziana Life Sciences, Ltd. (Nasdaq: TLSA) (“Tiziana”), a biotechnology company developing its lead candidate, intranasal foralumab, a fully human, anti-CD3 monoclonal antibody, announces the ...

Our thoughts are with the friends and family of Steve as well as all those who have lost a loved one on our latest list ...

Tiziana Life Sciences ( ($TLSA) ) just unveiled an update. On December 29, 2025, Tiziana Life Sciences reported that it has filed its seventh ...

Genetic treatments could be the key to unlocking some rare diseases. But bringing these medicines to patients involves ...

PALOMA study is one of the largest longitudinal studies using eye-movement biomarkers in patients with Parkinson’s diseaseNEW YORK & TEL AVIV, Israel--(BUSINESS WIRE)--NeuraLight, the leader in ...

SynuSight Biotech has licensed (18) F-FD4 to XingImaging and to ABLi Therapeutics to evaluate alpha-synuclein clearance from the brain in response to risvodetinib treatment ...